MTOR and cancer: Critically, many compounds that can suppress immunity are also antiproliferative; for instance, rapamycin, which modulates mTOR, is well known to be activated in cancer (Rad et al., 2018) and a modulator of mitochondrial function (Wei et al., 2015).